Nyxoah SA Long Term Debt 2021-2025 | NYXH

Nyxoah SA long term debt from 2021 to 2025. Long term debt can be defined as the sum of all long term debt fields.
Nyxoah SA Annual Long Term Debt
(Millions of US $)
2024 $23
2023 $12
2022 $11
2021 $12
2020 $12
Nyxoah SA Quarterly Long Term Debt
(Millions of US $)
2025-06-30 $24
2025-03-31 $22
2024-12-31 $23
2024-09-30 $24
2024-06-30 $12
2024-03-31 $13
2023-12-31 $12
2023-09-30 $12
2023-06-30 $12
2023-03-31 $12
2022-12-31 $11
2022-09-30 $11
2022-06-30 $12
2022-03-31 $12
2021-12-31
2021-03-31 $13
2020-12-31 $12
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.201B $0.005B
Nyxoah SA is a medical technology company. It focused on the development and commercialization of solutions to treat Obstructive Sleep Apnea. Nyxoah SA is based in Belgium.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $48.674B 59.39
Tempus AI (TEM) United States $12.352B 0.00
Doximity (DOCS) United States $9.545B 39.50
Hims & Hers Health (HIMS) United States $8.883B 72.26
IRhythm Technologies (IRTC) United States $5.771B 0.00
Hinge Health (HNGE) United States $3.320B 0.00
Heartflow (HTFL) United States $2.981B 0.00
Privia Health (PRVA) United States $2.979B 186.31
Inspire Medical Systems (INSP) United States $2.642B 43.71
10x Genomics (TXG) United States $2.078B 0.00
Enovis (ENOV) United States $1.787B 9.38
Omnicell (OMCL) United States $1.654B 33.82
Azenta (AZTA) United States $1.410B 61.54
Phreesia (PHR) United States $1.387B 0.00
Schrodinger (SDGR) United States $1.323B 0.00
Clover Health Investments (CLOV) United States $1.286B 0.00
Claritev (CTEV) United States $0.966B 0.00
Fulgent Genetics (FLGT) United States $0.899B 0.00
Butterfly Network (BFLY) United States $0.571B 0.00
Talkspace (TALK) United States $0.562B 113.00
Veradigm (MDRX) United States $0.536B 0.00
Evolent Health (EVH) United States $0.523B 0.00
Standard BioTools (LAB) United States $0.454B 0.00
Zepp Health (ZEPP) Netherlands $0.369B 0.00
Carlsmed (CARL) United States $0.328B 0.00
TruBridge (TBRG) United States $0.303B 13.93
SOPHiA GENETICS SA (SOPH) Switzerland $0.292B 0.00
CapsoVision (CV) United States $0.259B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.243B 0.00
MDxHealth SA (MDXH) Belgium $0.195B 0.00
KORU Medical Systems (KRMD) United States $0.175B 0.00
Health Catalyst (HCAT) United States $0.174B 0.00
CareCloud (CCLD) United States $0.136B 7.45
EUDA Health Holdings (EUDA) Singapore $0.110B 0.00
Outset Medical (OM) United States $0.101B 0.00
Pulmonx (LUNG) United States $0.080B 0.00
NetraMark Holdings (AINMF) Canada $0.076B 0.00
American Well (AMWL) United States $0.066B 0.00
HeartBeam (BEAT) United States $0.057B 0.00
P3 Health Partners (PIII) United States $0.055B 0.00
Evaxion - (EVAX) Denmark $0.038B 0.00
111 (YI) China $0.035B 0.00
Precipio (PRPO) United States $0.032B 0.00
Predictive Oncology (POAI) United States $0.028B 0.00
Lunai Bioworks (LNAI) United States $0.021B 0.00
Zhongchao (ZCMD) China $0.017B 0.00
Healthcare Triangle (HCTI) United States $0.015B 0.00
Bullfrog AI Holdings (BFRG) United States $0.011B 0.00
Movano (MOVE) United States $0.010B 0.00
Strata Skin Sciences (SSKN) United States $0.009B 0.00
PROFUSA (PFSA) United States $0.008B 0.00
HeartSciences (HSCS) United States $0.008B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.002B 0.00
MSP Recovery (MSPR) United States $0.001B 0.00